Clinical Trial Update: Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy [Phase 1]

View source ↗

Summary

Phase 1 exploratory study evaluating norepinephrine to prevent alopecia and radiodermatitis in head and neck cancer patients undergoing radiotherapy; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia
• Radiodermatitis

Drugs mentioned

• NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

Snippet

Sponsor: ProCertus BioPharm, Inc | Conditions: Alopecia, Radiodermatitis | Phase 1 | Status: TERMINATED